欢迎使用我们的服务!
限时优惠,立即购买享受折扣
24小时客服在线,随时为您服务
优质产品,值得信赖
印度仿制药专卖店
导航菜单
首页
选购指南
订单查询
登录
0
购物车
0 件商品
购物车是空的
总计:
¥0.00
查看购物车
亮色
暗色
自动
顶
置
文章列表
FDA approves Tivicay pd for youngest HIV patients
2026-09-09
Oncology Trial Waivers In India: Big Pharma, Local Firms Navigate Path To Faster Entry
2026-09-09
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
2026-09-09
Pipeline Watch: Two Approvals And Ten Phase III Readouts
2026-09-09
Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%
2026-09-08
New EU supply chain to end Visudyne shortage
2026-09-08
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2026
2026-09-08
Aurobindo Receives FDA Approval for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg
2026-09-08
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
2026-09-08
Biocon Announces Pegfilgrastim Biosimilar Marketing Approval by Japan Ministry of Health, Labour and Welfare (MHLW)
2026-09-07
Sun Pharma Participates in White House Signing Ceremony Highlighting U.S. Medicines Pricing and Access Commitments
2026-09-07
Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%
2026-09-07
‹
1
2
...
6
7
8
9
10
11
12
...
70
71
›